India Pharma Outlook Team | Tuesday, 14 April 2026
AI in healthcare is moving from promise to practice as multiple states in India roll out new tech-driven initiatives to improve diagnosis, training, and patient care.
In Madhya Pradesh, the state government has launched a pilot program across 10 district hospitals in partnership with Canadian firm mlHealth360.
The initiative brings a cloud-based AI radiology platform into public hospitals to analyze CT scans, flag abnormalities, and generate standardized reports. The system integrates with existing imaging workflows, helping doctors quickly identify critical cases like stroke, trauma, tumors, and internal bleeding.
By prioritizing urgent scans, hospitals aim to cut delays and improve response time. The rollout will begin with system checks and integration, followed by clinician training before full deployment. If successful, the program could expand statewide.
Also Read: India's Path to Billion-Dollar Drugs: Building a Strong Ecosystem
Meanwhile, Telangana has introduced an AI-powered lung cancer screening program across 20 public healthcare facilities in collaboration with AstraZeneca Pharma India. The system uses Qure.ai’s chest X-ray analysis software to detect lung nodules and other conditions, helping doctors identify high-risk patients earlier. The move comes as cancer cases in the state are expected to rise steadily by 2030. This effort builds on similar programs already running in states like Goa, Tamil Nadu, and Karnataka.
AI in healthcare India is also advancing medical education. In New Delhi, AIIMS has opened a virtual reality training center at its SET Facility in collaboration with MediSim VR. The center will support immersive learning and research, with plans to include VR in medical and nursing education. The goal is to improve hands-on training, standardize learning, and build stronger clinical skills.
Together, these efforts show how technology is reshaping healthcare delivery across India.
.jpg)
